1637677-33-8 (Povorcitinib phosphate,Povorcitinib phosphate)

Benzamide, 4-[3-(cyanomethyl)-3-(3',5'-dimethyl[4,4'-bi-1H-pyrazol]-1-yl)-1-azetidinyl]-2,5-difluoro-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-, phosphate (1:1);Povorcitinib phosphate;(S)-4-(3-(Cyanomethyl)-3-(3',5'-dimethyl-1H,1'H-(4,4'-bipyrazol)-1-yl)azetidin-1-yl)-2,5-difluoro-N-(1,1,1-trifluoropropan-2-yl)benzamide phosphate;INCB054707 PHOSPHATE;AKOS040756954;POVORCITINIB PHOSPHATE [USAN];Povorcitinib phosphate (USAN);DA-66837;1637677-33-8;HY-145588A;Povorcitinib (phosphate);4-[3-(cyanomethyl)-3-(3',5'-dimethyl-1H,1'H-4,4'-bipyrazol-1-yl)azetidin-1-yl]-2,5-difluoro-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide phosphoric acid salt;AT40320;SCHEMBL16240423;4-[3-(cyanomethyl)-3-[4-(3,5-dimethyl-1H-pyrazol-4-yl)pyrazol-1-yl]azetidin-1-yl]-2,5-difluoro-N-[(2S)-1,1,1-trifluoropropan-2-yl]benzamide;phosphoric acid;MLO3DS9COC;CHEMBL5314592;INCB-054707 PHOSPHATE;Benzamide, 4-(3-(cyanomethyl)-3-(3',5'-dimethyl(4,4'-bi-1H-pyrazol)-1-yl)-1-azetidinyl)-2,5-difluoro-N-((1S)-2,2,2-trifluoro-1-methylethyl)-, phosphate (1:1);UNII-MLO3DS9COC;D12576;

XUQIWHXYCLHHCN-UQKRIMTDSA-N

1S/C23H22F5N7O.H3O4P/c1-12-20(13(2)33-32-12)15-8-30-35(9-15)22(4-5-29)10-34(11-22)19-7-17(24)16(6-18(19)25)21(36)31-14(3)23(26,27)28;1-5(2,3)4/h6-9,14H,4,10-11H2,1-3H3,(H,31,36)(H,32,33);(H3,1,2,3,4)/t14-;/m0./s1

P(O)(O)(O)=O.C(C1(N2N=CC(C3=C(NN=C3C)C)=C2)CN(C2C=C(F)C(C(=O)N[C@@H](C)C(F)(F)F)=CC=2F)C1)C#N